Synedgen: Funding, Investors & Team (Oct 2026)
Synedgen, established in 2009 through the merger of BioSTAR West and Hawaii Chitopure, is a biopharmaceutical company dedicated to creating new therapies and products that combat infection and inflammation on various body surfaces. It utilizes innovative polysaccharide derivatives to target bacteria entry points in the body and promote healing post-infection or damage. The company is led by a team of experienced professionals with expertise in various fields such as chemistry, microbiology, regulatory processes, and fundraising.
Synedgen has raised $6.2M across 2 funding rounds on record, the most recent an undisclosed round of $1.8M announced in Oct 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Synedgen Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Synedgen Funding Rounds
Synedgen raised $4.4M in an undisclosed round announced in Apr 2024.
6 months later, an undisclosed round of $1.8M was announced in Oct 2024.
Synedgen Founders and Leadership Team
No contact details are on record for this team yet.
Synedgen Funding Compared to Other Biotechnology Startups
Synedgen's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synedgen in Biotechnology and Claremont
Companies Similar to Synedgen
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Synedgen Funding FAQs
What does Synedgen do?
Synedgen, established in 2009 through the merger of BioSTAR West and Hawaii Chitopure, is a biopharmaceutical company dedicated to creating new therapies and products that combat infection and inflammation on various body surfaces. It utilizes innovative polysaccharide derivatives to target bacteria entry points in the body and promote healing post-infection or damage. The company is led by a team of experienced professionals with expertise in various fields such as chemistry, microbiology, regulatory processes, and fundraising.
How much funding has Synedgen raised?
Synedgen has raised $6.2M across 2 rounds on record. The most recent is an undisclosed round of $1.8M announced in Oct 2024.
When did Synedgen last raise funding?
Synedgen's most recent funding round on record is an undisclosed round of $1.8M, announced in Oct 2024.
Who founded Synedgen?
FundedIQ lists William P Wiesmann (Founder) at Synedgen.
Where is Synedgen headquartered?
Synedgen is based in Claremont, California, United States.
How many employees does Synedgen have?
Synedgen is in the 11-50 employee band.
How does Synedgen's funding compare to other Biotechnology startups?
Synedgen's latest round of $1.8M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Synedgen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synedgen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.